Medical Licensing (MD/DO) · Independent exam preparation
Geriatric Psychiatry Certification: Clinical Reasoning Guide Study Guide
Distinguish delirium, neurocognitive disorders, mood illness, psychosis, and medication harm; practise safer treatment, diagnostic testing, consent, and coordinated care in older adults.
By CertMedbry · Updated 17 October 2026
Practise distinguishing acute cognitive change from progressive disease, identifying primary and medication-related psychiatric syndromes, and choosing safer treatments for older adults. These 60 selective concepts connect clinical findings with mechanisms, diagnostic decisions, communication, and coordinated care. The official ABPN content outline defines the full examination scope, including disorders and procedures beyond this guide: https://abpn.org/wp-content/uploads/Geriatric-Psychiatry-Certification-Content-Specifications.pdf.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification examination does this guide address?
This guide addresses the American Board of Psychiatry and Neurology, Inc. initial Certification Examination in Geriatric Psychiatry, a physician subspecialty board certification examination. It is not a medical licensing examination. ABPN changed the certificate designation from Added Qualifications to Certification in the Subspecialty of Geriatric Psychiatry in February 1997. Continuing certification is a separate pathway and its outline is not used here.
What training pathway is described by the initial-certification page?
ABPN requires certification in general psychiatry by December 31 of the year before the examination and, apart from the historical 1991–1998 practice pathway, documentation of one year of ACGME-accredited geriatric psychiatry fellowship training after completion of general psychiatry residency. Licensing and training requirements must be met by July 31 of the examination year. The historical practice pathway is not presented as a current alternative. ABPN states that it does not currently accept training from international programs.
How many questions are delivered, and how many are scored?
The examination delivers 220 questions in four sections of 55. The format document states that questions included solely for research or pretesting are excluded from scoring, but it does not specify their number. Consequently, an exact scored-question count cannot be established from these documents.
How much time is available, including breaks?
Total testing time is 240 minutes: five minutes for the nondisclosure agreement and instructions, 230 minutes for the questions, and five minutes for the final survey. Optional breaks occur between sections, and examination time continues during those breaks. A proctor must log examinees back in after breaks.
What delivery method and item styles are verified?
The examination is computer delivered and consists entirely of stand-alone, one-best-answer multiple-choice questions. Questions can be skipped or flagged for review. The published structure has four sections; the document does not describe computer-adaptive delivery. The initial-certification page identifies Pearson VUE registration. The 20 questions in this guide are independent learning drills.
Geriatric Psychiatry Certification Format and Scoring · ABPN — Geriatric Psychiatry: Initial Certification
Which blueprint version applies, and how do its dimensions relate?
The content specifications are marked Posted: March 2026; no separate effective date is stated. The currently linked format document is updated May 23, 2025. Each examination question maps to both a disorder/topic and a competency/mechanism, so the dimensions must not be added together. Competency ranges are A 7–9%, B 4–6%, C 23–27%, D 10–14%, E 31–35%, F 1–3%, G 2–4%, H 1–3%, and I 8–12%. This selective guide approximates those proportions; small question and flashcard sets cannot reproduce every range exactly.
Geriatric Psychiatry Certification Content Specifications · Geriatric Psychiatry Certification Format and Scoring
Which disorder areas receive the greatest blueprint emphasis?
The disorder/topic dimension assigns neurocognitive disorders 13–17%; depressive disorders and other conditions that may be a focus of clinical attention 8–12% each; substance-related and addictive disorders and anxiety disorders 7–9% each; schizophrenia spectrum and other psychotic disorders and bipolar and related disorders 5–7% each; and neurologic disorders 4–6%. The official outline also includes numerous smaller categories. Those categories remain part of the full scope even when this guide samples them lightly or does not address them individually.
What scoring information is published?
ABPN reports a total percent-correct score and subtest scores. Passing requires an acceptable total-score performance; standards are not norm referenced and there is no predetermined group passing rate. The document gives no numerical passing cutoff. There is no penalty for guessing, and ABPN advises answering every question.
These independently authored learning materials emphasize reasoning across intersecting disorder and competency dimensions. The original cases and hypothetical trial results are educational exercises, not ABPN examination questions or predictors of passing.
Outline used: ABPN Geriatric Psychiatry Certification Content Specifications, 15 pages, marked Posted: March 2026; opened through the current initial-certification examination page on 2026-10-09. A separate effective date was not stated. The workbook label American Board of Psychiatry and Neurology - Subspecialty in Geriatric Psychiatry maps to this initial subspecialty certification examination; the assigned canonical slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
A. Neuroscience and mechanisms of disease7-9%
1.How does dopamine loss produce parkinsonian movement symptoms?
Parkinson disease involves loss of dopamine-producing neurons in the substantia nigra, disrupting circuits that help initiate and regulate movement. Bradykinesia, rigidity, resting tremor, and impaired balance are characteristic clinical consequences. The discriminating principle is a movement syndrome supported by examination, rather than depression, fatigue, or slowed speech alone. Psychiatric assessment should establish whether reduced activity reflects motor impairment, mood symptoms, medication effects, or several processes occurring together.
Apply it
A 76-year-old reports feeling slowed down. Examination shows reduced arm swing, rigidity, and a resting hand tremor. These findings justify evaluation for parkinsonism even though the patient also describes low motivation and poor sleep.
Common pitfall: Attributing all slowing to depression overlooks objective motor signs. Conversely, a complaint of fatigue without bradykinesia or rigidity does not establish Parkinson disease.
2.What pathology connects Lewy body disease with cognitive and motor symptoms?
Lewy body disease is associated with abnormal aggregates of alpha-synuclein within neurons. Its clinical expression can involve cognitive, motor, autonomic, and sleep systems, explaining why hallucinations, parkinsonism, fluctuations, and dream enactment may coexist. The anatomical distribution and accompanying pathologies influence presentation. A useful decision is to recognize a coherent multisystem syndrome rather than assigning each feature to an unrelated psychiatric diagnosis or assuming that every dementia begins with prominent memory loss.
Apply it
A patient with progressive cognitive impairment also has recurrent visual hallucinations, constipation, and dream enactment. Their combination supports investigating Lewy body disease rather than treating the hallucinations as an isolated late-onset psychotic disorder.
Common pitfall: Alpha-synuclein pathology is not established by symptoms alone. Clinical diagnostic criteria and appropriate investigations guide the diagnosis; the syndrome does not require biopsy confirmation.
Diagnosis and Management of Dementia with Lewy Bodies: Fourth Consensus Report
3.How do Alzheimer pathology and medial temporal injury relate to cognitive findings?
Alzheimer disease is associated with amyloid plaques and tau-containing neurofibrillary tangles. Injury involving medial temporal structures, including the hippocampus, helps explain prominent difficulty learning and retaining new information. The DLB consensus report describes greater medial temporal atrophy in Alzheimer disease than in typical dementia with Lewy bodies and relates hippocampal atrophy particularly to tangle pathology. These associations help explain a clinical pattern but do not make one symptom or structural scan pathologically specific. Alzheimer and Lewy body changes frequently coexist.
Apply it
An older adult has progressive difficulty retaining recent conversations and medial temporal atrophy. This combination supports an Alzheimer differential, while early hallucinations and fluctuations would also raise concern for accompanying Lewy body disease.
Common pitfall: Medial temporal atrophy is supporting evidence, not a stand-alone diagnosis. Mixed pathology can produce a presentation that does not fit a single textbook pattern.
Diagnosis and Management of Dementia with Lewy Bodies: Fourth Consensus Report
4.Why does abrupt alcohol cessation cause hyperexcitability?
Chronic heavy alcohol exposure produces adaptations in inhibitory GABA and excitatory glutamate signaling. When alcohol is abruptly reduced, these adaptations can leave relatively excessive excitation, producing tremor, autonomic activation, agitation, seizures, and withdrawal delirium. Benzodiazepines address this physiology through GABA-A receptor effects. The key decision is to recognize withdrawal as a potentially dangerous neurophysiologic state, rather than treating tachycardia and anxiety as ordinary distress or suppressing hallucinations without controlling withdrawal.
Apply it
An older inpatient becomes tremulous, sweaty, and tachycardic after a sudden interruption of heavy daily drinking. The timing and autonomic findings suggest withdrawal physiology requiring monitored assessment and treatment rather than reassurance alone.
Common pitfall: A positive blood alcohol concentration does not exclude withdrawal when the level is falling from a chronically high baseline. Clinical trajectory and exposure history matter.
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
B. Behavioral/social sciences and psychosocial mechanisms of diseases4-6%
6.How does cultural context change the interpretation of grief?
Grief must be interpreted in relation to the person's social, cultural, and religious context, including customary mourning practices and expectations about continuing bonds. Duration alone does not establish prolonged grief disorder. Persistent separation distress, the required additional symptoms and frequency, clinically significant distress or impairment, and a response exceeding contextual expectations must be established. Ask how the loss affects distress, functioning, and meaning, rather than assuming that unfamiliar rituals, visible emotion, or ongoing remembrance indicate psychopathology in themselves.
Apply it
Fourteen months after a death, a patient continues a daily remembrance ritual but maintains relationships and responsibilities. Explore its meaning, associated distress, and the complete symptom pattern before interpreting the ritual as evidence of prolonged grief disorder.
Common pitfall: Using the clinician's own mourning customs as the diagnostic standard risks pathologizing difference. Preserved functioning does not exclude the disorder when the complete syndrome causes clinically significant distress.
American Psychiatric Association — Prolonged Grief Disorder · Psychiatry.org - APA Offers Tips for Understanding Prolonged Grief Disorder
7.Why can avoidance maintain an anxiety disorder?
Avoidance can reduce distress immediately while preventing corrective learning about feared situations or uncertainty. This short-term relief reinforces the behavior, allowing anxiety and functional restriction to persist. Cognitive behavioral therapy addresses patterns of thinking and behavior that sustain anxiety rather than relying only on reassurance. A useful clinical distinction is between a proportionate precaution and a repeated avoidance strategy that increasingly narrows everyday activities despite little evidence of actual danger.
Apply it
An older adult repeatedly cancels appointments because of worries about making mistakes outside the home. Cancellation brings immediate relief, but confidence declines. Identifying this cycle helps explain the rationale for structured behavioral work.
Common pitfall: Telling a patient simply to stop worrying does not change the maintaining cycle. Behavioral goals should be collaborative, realistic, and adapted to actual medical limitations.
8.How does baseline risk affect absolute treatment benefit?
Absolute risk reduction is the untreated event risk minus the treated event risk over a specified period. Number needed to treat is its reciprocal when risks are expressed as proportions, conventionally rounded up for a beneficial outcome. The same relative reduction can yield different absolute benefits at different baseline risks. Interpretation therefore requires the event definition, time horizon, comparison group, and population, especially when applying trial results to older adults with different comorbidity profiles.
Apply it
In a hypothetical trial, relapse occurs in 30% of controls and 20% of treated participants over one year. The absolute reduction is 0.10, giving a one-year number needed to treat of 10.
Common pitfall: A relative reduction of one third does not mean one third of all treated patients benefit. Absolute benefit depends on baseline risk and follow-up duration.
Cochrane Handbook — Chapter 15: Interpreting Results and Drawing Conclusions
C. Clinical aspects of psychiatric and neuropsychiatric disorders23-27%
9.Which findings distinguish delirium from a stable cognitive disorder?
Delirium is characterized by an acute change in mental state, impaired attention, and a fluctuating course, usually arising from illness, medications, intoxication, or withdrawal. A prior cognitive disorder increases vulnerability but does not explain away a new change. Compare current function with baseline and look for a precipitating cause. The decisive distinction is the time course and disturbance of attention, rather than whether memory loss, hallucinations, or disorientation happen to be present.
Apply it
A patient with stable dementia becomes intermittently inattentive and unusually quiet over two days after surgery. The acute departure from baseline supports superimposed delirium rather than an immediate assumption of dementia progression.
Common pitfall: Delirium need not involve agitation. A sleepy, withdrawn presentation can be missed if assessment focuses only on disruptive behavior or the presence of hallucinations.
10.What clinical pattern supports probable dementia with Lewy bodies?
Dementia is the essential requirement for dementia with Lewy bodies. Core clinical features are fluctuating cognition, recurrent well-formed visual hallucinations, REM sleep behavior disorder, and spontaneous parkinsonism. Probable disease is supported by at least two core features, or one core feature plus an indicative biomarker. Early deficits may emphasize attention, executive function, and visuoperceptual processing. Memory complaints alone are less discriminating than the combination and chronology of these characteristic clinical findings.
Apply it
A patient with progressive loss of independence has recurrent detailed visual hallucinations and spontaneous rigidity with bradykinesia. These two core features support probable dementia with Lewy bodies even without an indicative biomarker.
Common pitfall: An indicative biomarker without a core clinical feature does not by itself establish probable dementia with Lewy bodies. Apply the complete diagnostic framework.
Diagnosis and Management of Dementia with Lewy Bodies: Fourth Consensus Report
11.Which cognitive pattern favors Alzheimer disease, and what determines major versus mild impairment?
A typical Alzheimer presentation develops insidiously and progresses over time, with prominent difficulty learning and retaining recent information. Language, visuospatial, and executive deficits can emerge as disease progresses. Early recurrent visual hallucinations, pronounced fluctuations, dream enactment, or spontaneous parkinsonism increase concern for Lewy body disease. Major neurocognitive disorder interferes with independent everyday functioning; mild neurocognitive disorder preserves independence, sometimes through greater effort or compensatory strategies. Establish both the cognitive syndrome and its functional consequences before assigning an etiologic diagnosis.
Apply it
Over three years, a patient increasingly repeats questions and forgets recent events, then needs help managing medication and finances because of cognitive errors. The progressive amnestic pattern supports an Alzheimer differential, and the loss of independence supports major impairment.
Common pitfall: A low screening score alone does not determine functional severity or etiology. Abrupt inattention requires delirium assessment, and mixed Alzheimer, vascular, and Lewy body contributions can coexist.
Geriatric Psychiatry Certification Content Specifications · Diagnosis and Management of Dementia with Lewy Bodies: Fourth Consensus Report · American Psychiatric Association — DSM-5-TR Update, September 2024, with Previous Updates
12.What establishes a major depressive episode, and when is the disorder major depressive disorder?
A major depressive episode requires at least five symptoms during the same two-week period, representing a change from baseline; at least one must be depressed mood or loss of interest or pleasure. Other symptoms involve appetite or weight, sleep, observable psychomotor change, energy, worthlessness or excessive guilt, concentration or decisions, and recurrent thoughts of death or suicide. Most symptoms occur nearly every day; depressed mood and anhedonia occur most of the day. Weight change and recurrent suicidal thoughts have distinct frequency wording. Symptoms cause clinically significant distress or impairment and require assessment of substance, medication, medical, and psychiatric explanations. An episode alone does not establish major depressive disorder: a qualifying history of mania or hypomania changes the disorder diagnosis toward bipolar illness.
Apply it
For a month, a patient has anhedonia most of each day, early waking, fatigue, reduced appetite, and worthlessness nearly every day, with clear functional decline. This meets the symptom-count and duration requirements for an episode, while lifetime mood history and exclusions determine the disorder diagnosis.
Common pitfall: Insomnia and fatigue alone are insufficient. Do not diagnose major depressive disorder without asking about previous mania or hypomania; bereavement can coexist with a depressive episode.
13.How can ordinary grief and depression differ clinically?
Grief often comes in waves associated with reminders of the deceased, and positive memories or preserved self-esteem may remain accessible. Depression more often produces pervasive low mood, diminished interest, and feelings of worthlessness or self-loathing. These patterns help organize the interview but do not create an absolute separation: bereavement and major depression can coexist. Assess persistence, functional impairment, and suicidal thinking rather than withholding evaluation solely because symptoms followed a death.
Apply it
After losing a spouse, a patient has periods of sadness but still enjoys family visits. Another describes unremitting worthlessness and loss of all pleasure. Their different patterns guide further assessment rather than determining diagnosis from bereavement alone.
Common pitfall: Bereavement does not rule out major depression. Presuming all post-loss symptoms are normal grief can miss severe impairment, pervasive self-devaluation, or an emerging suicide crisis.
14.When should new psychosis raise concern about corticosteroids?
Systemic corticosteroids can cause psychiatric effects ranging from insomnia and mood changes to severe depression and psychotic manifestations. New symptoms following initiation or a substantial exposure change should prompt review of the temporal relationship, other medicines, medical illness, and attention. Medication-induced psychosis is a differential diagnosis, not a conclusion established by timing alone. Fluctuating inattention would redirect assessment toward delirium, while clear consciousness permits closer characterization of mood and psychotic syndromes.
Apply it
A previously psychiatrically well patient develops suspiciousness and voices after prednisone is started. Attention remains intact. Review steroid exposure and competing causes before labeling the episode as a new primary schizophrenia-spectrum illness.
Common pitfall: Do not abruptly stop a necessary corticosteroid without medical coordination. Identifying a possible adverse effect should lead to a joint risk-benefit plan with the prescriber.
DailyMed — Prednisone Delayed-Release Tablets Prescribing Information
15.How does lifetime episode history distinguish primary bipolar illness from unipolar depression?
Mania requires abnormally elevated, expansive, or irritable mood with increased energy or activity for at least seven days, present most of the day nearly every day, or any duration when hospitalization is necessary. Hypomania requires at least four consecutive days with the same daily pattern. Both require at least three associated symptoms, or four when mood is only irritable: grandiosity, decreased need for sleep, increased speech, racing thoughts, distractibility, increased goal-directed activity or psychomotor agitation, and risky behavior. Mania causes marked impairment, requires hospitalization, or includes psychosis; hypomania produces an observable change without marked impairment, hospitalization, or psychosis. A manic episode establishes bipolar I; bipolar II requires hypomania and major depression with no mania. Assess medication, substance, and medical causes, especially with new late-life activation. A full antidepressant-emergent episode persisting beyond the treatment's physiological effects can qualify; brief activation alone does not. See [SAMHSA diagnostic criteria](https://www.ncbi.nlm.nih.gov/books/NBK571021/box/ch4.b6/?report=objectonly).
Apply it
An older adult seeking depression treatment previously had eight days of expansive mood, increased energy, little need for sleep, grandiosity, rapid speech, and reckless spending, leading to hospitalization without a causative exposure. This supports bipolar I. Two days of jitteriness and insomnia with fatigue after starting an antidepressant would not establish a qualifying episode.
Common pitfall: Severity alone does not replace duration and symptom-count requirements. Decreased need for sleep means feeling rested despite little sleep; insomnia with fatigue is different.
16.What distinguishes generalized anxiety disorder from temporary worry?
Generalized anxiety disorder requires excessive anxiety and worry about multiple concerns, occurring more days than not for at least six months and difficult to control. Adults require at least three of six associated symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, or sleep disturbance. At least some associated symptoms are present more days than not during the six months. The syndrome causes clinically significant distress or impairment and is not attributable to a substance, medication, or medical condition or better explained by another mental disorder. Duration alone is insufficient.
Apply it
For eight months, a patient has excessive, difficult-to-control worry about finances, relatives, and appointments most days. Muscle tension, fatigue, and disturbed sleep accompany it and interfere with daily activities. After exclusions are assessed, this pattern supports generalized anxiety disorder.
Common pitfall: Two associated symptoms do not meet the adult three-of-six threshold. A realistic concern can coexist with pathological anxiety, but assess excessiveness, control, impairment, and alternative explanations.
17.How do duration and mood timelines distinguish primary psychotic syndromes?
Schizophrenia requires at least six months of continuous disturbance, including at least one month of active symptoms, or less if successfully treated. The active phase requires at least two characteristic symptoms, with at least one being delusions, hallucinations, or disorganized speech; the other categories are grossly disorganized or catatonic behavior and negative symptoms. Functional decline is required. Schizophreniform disorder has the same active symptom pattern but lasts one to less than six months and does not require functional decline. Schizoaffective disorder requires a major mood episode concurrent with schizophrenia symptoms, at least two weeks of delusions or hallucinations without a major mood episode, and major mood episodes during most of the total active and residual illness. Psychosis occurring exclusively during major mood episodes favors a mood disorder with psychotic features. Assess medication, substance, medical, neurological, and delirium explanations before assigning a primary disorder.
Apply it
Over twelve months of continuous psychotic illness, a patient has a one-month depressive episode and eleven months without a major mood episode; with the remaining criteria met, this favors schizophrenia. If major mood episodes occupy nine months, overlap the schizophrenia syndrome, and at least two weeks of delusions or hallucinations occur without a major mood episode, schizoaffective disorder is favored. The same schizophrenia symptom pattern lasting only three months instead supports schizophreniform disorder.
Common pitfall: Two weeks of psychosis without a major mood episode is necessary but insufficient for schizoaffective disorder: mood episodes must also occupy most of the active and residual course. Hallucinations alone do not establish schizophrenia.
18.Which features distinguish hoarding disorder from collecting?
Hoarding disorder involves persistent difficulty discarding possessions because of a perceived need to save them and distress associated with discarding. Accumulation compromises the intended use of living spaces and causes distress or impairment. Organized collecting ordinarily preserves usable space and does not produce the same functional disruption. Assess safety, insight, acquisition, and alternative explanations, including cognitive disease, rather than diagnosing from the number or monetary value of possessions alone.
Apply it
A patient keeps newspapers across the stove and cannot use the kitchen, becoming intensely distressed when discarding is discussed. The impaired use of living space distinguishes this problem from an organized newspaper collection.
Common pitfall: An untidy room or an unusual collection is insufficient. Conversely, a patient's limited recognition of risk does not make blocked exits and unusable rooms harmless.
19.When does persistent bereavement suggest prolonged grief disorder?
For adults, prolonged grief disorder requires a death at least twelve months earlier, persistent yearning or preoccupation, and at least three associated symptoms: identity disruption, disbelief, avoidance, intense emotional pain, difficulty reintegrating, numbness, meaninglessness, or loneliness. The required symptoms occur nearly every day for at least the preceding month; separation distress is present most days to a clinically significant degree. The disturbance causes clinically significant distress or impairment and exceeds social, cultural, or religious expectations. It must not be better explained by another mental disorder or attributable to a substance, medication, or medical condition. Time since death is necessary but does not establish the diagnosis by itself.
Apply it
Sixteen months after a death, a patient has daily yearning, disbelief, identity disruption, and loneliness, occurring nearly every day for two months and exceeding cultural expectations. Severe clinically significant distress can satisfy the consequence criterion even if the patient continues essential responsibilities; substantial functional impairment is another qualifying consequence.
Common pitfall: Persistent sadness alone is insufficient. Confirm the symptom pattern, required frequency, clinically significant distress or impairment, contextual expectations, and exclusions.
American Psychiatric Association — Prolonged Grief Disorder · Psychiatry.org - APA Offers Tips for Understanding Prolonged Grief Disorder
20.What makes somatic symptom disorder a positive clinical diagnosis?
Somatic symptom disorder requires distressing or disruptive bodily symptoms accompanied by excessive symptom-related thoughts, anxiety, or behavior. The symptomatic state is persistent, typically lasting more than six months; the same individual symptom need not remain continuously present. This duration describes persistence rather than an inflexible cutoff. Symptoms may occur with a diagnosed medical condition and need not be medically unexplained. The positive evidence is a disproportionate cognitive, emotional, or behavioral response with significant consequences, assessed while appropriate medical care continues.
Apply it
For nine months, a patient with stable arthritis has spent hours checking bodily symptoms and repeatedly seeking urgent reassurance despite a consistent care plan. Assess the persistent excessive response and functional disruption while continuing treatment of the genuine joint disease.
Common pitfall: Normal tests do not establish somatic symptom disorder, and a transient excessive response is insufficient. Excessive health-related distress does not imply deliberate fabrication.
American Psychiatric Association — Somatic Symptom Disorder · APA_DSM-5-Somatic-Symptom-Disorder.pdf
21.What evidence supports vascular contributions to a neurocognitive disorder?
Establish acquired cognitive decline with objective assessment, then determine whether cerebrovascular disease plausibly explains the deficits. The [VasCog-2-WSO diagnostic consensus (2025)](https://jamanetwork.com/journals/jamaneurology/fullarticle/2839119) requires compatible clinical features and significant cerebrovascular imaging findings for predominantly vascular attribution. Abrupt decline associated with stroke supports causation; its poststroke guidance describes deficits persisting beyond three months. Multiple strokes can produce stepwise decline. Subcortical ischemic disease can instead cause gradual progression with prominent slowing, impaired attention, and executive dysfunction. Relevant imaging includes strategically located infarction, multiple lacunes, or extensive confluent white-matter hyperintensities. Alzheimer pathology and vascular injury can coexist.
Apply it
Four months after a documented thalamic infarct, a previously independent patient has objectively demonstrated slowing and planning deficits and needs help managing medications. The new deficits began with the stroke, and MRI confirms the corresponding lesion. Together, chronology, cognitive testing, functional change, and lesion location support vascular contribution.
Common pitfall: Hypertension alone does not establish vascular causation, and minor incidental white-matter abnormalities do not adequately explain substantial cognitive impairment. Interpret lesion burden and location alongside the clinical syndrome. The vascular consensus supplies diagnostic evidence; the ABPN outline establishes blueprint alignment, the DSM supplement supplies coding updates, and the DLB consensus supports the Lewy body differential. This selective 60-concept guide does not replace the official outline's full scope.
Geriatric Psychiatry Certification Content Specifications · American Psychiatric Association — DSM-5-TR Update, September 2024, with Previous Updates · Diagnosis and Management of Dementia with Lewy Bodies: Fourth Consensus Report
22.Which changes suggest frontotemporal neurocognitive disease rather than a new mood or personality disorder?
Behavioral-variant frontotemporal dementia requires progressive deterioration of behavior or cognition. Possible disease requires at least three of six persistent or recurrent features: early disinhibition, apathy or inertia, loss of empathy, perseverative or compulsive behavior, hyperorality or dietary change, and executive deficits with relative sparing of episodic memory and visuospatial functions. Probable disease additionally requires significant functional decline and characteristic frontal or anterior temporal atrophy, hypoperfusion, or hypometabolism. Exclude better medical or psychiatric explanations; biomarkers strongly indicating another neurodegenerative process prevent a probable classification. Frontotemporal syndromes can also present with progressive language impairment, but those presentations require their own assessment rather than automatic application of behavioral-variant criteria.
Apply it
A previously considerate patient develops progressive tactlessness, loss of empathy, rigid routines, and altered eating over two years. These recurrent features support possible behavioral-variant disease after exclusions. Clear functional decline plus frontal or anterior temporal imaging abnormalities supports probable disease.
Common pitfall: Apathy alone is nonspecific, and preserved memory does not exclude neurodegeneration. A steadily progressive behavioral change differs from episodic mania and from a lifelong personality pattern; possible and probable disease require different evidence.
23.How should cognitive complaints be interpreted during depression?
Depression can impair concentration, thinking, and decision-making, producing cognitive complaints that overlap with neurocognitive disorders. Their presence does not establish a degenerative cause, and a depressive syndrome does not exclude concurrent cognitive disease. Establish the chronology, functional consequences, mood symptoms, and evidence of acute fluctuating attention. Follow cognitive performance and everyday functioning as depression is treated, rather than assuming that one interview can resolve every contribution to late-life cognitive difficulty.
Apply it
A patient reports forgetfulness beginning with a sustained depressive episode. Family also describes missed bills predating the mood change. Both timelines deserve assessment because treating depression alone may not explain the earlier functional decline.
Common pitfall: Promising that all cognitive symptoms will reverse with mood treatment overstates certainty. Equally, diagnosing dementia solely from concentration difficulty during depression can misclassify the presentation.
American Psychiatric Association — Depression · MedlinePlus — Delirium
D. Diagnostic procedures10-14%
24.Why is collateral history essential when cognition has changed?
Collateral history establishes baseline cognition, daily functioning, symptom onset, and fluctuation when self-report is incomplete. It is particularly valuable for distinguishing an acute change from a progressive disorder and for identifying hallucinations, dream enactment, or functional losses that the patient may not recognize. Ask informants for concrete examples and dates rather than diagnostic labels. Integrate their observations with direct examination and the patient's account while maintaining appropriate consent and confidentiality practices.
Apply it
A patient says nothing has changed, but a partner describes two days of fluctuating confusion after a new medicine. That collateral timeline changes the immediate diagnostic task from routine memory evaluation to assessment for delirium.
Common pitfall: Informants can also be mistaken or distressed. Treat collateral information as evidence to examine and reconcile, not as an automatic replacement for the patient's perspective.
MedlinePlus — Delirium · Diagnosis and Management of Dementia with Lewy Bodies: Fourth Consensus Report
25.What should a suicide safety assessment clarify after a positive screen?
A positive suicide screen requires assessment of current thoughts, frequency, intent, plans, access to means, past behavior, symptoms, stressors, and available support. Ask directly rather than relying on vague questions about coping. Current suicidal thoughts require urgent evaluation and the patient should not be left alone. A screening result identifies the need for assessment; it does not by itself determine the complete risk formulation, disposition, or level of supervision required.
Apply it
An older outpatient endorses wishing to die. Ask whether suicidal thoughts are present now, whether there is a plan, and whether the means are accessible. The answers determine whether immediate emergency evaluation is needed.
Common pitfall: A reassuring manner, family presence, or denial of one specific plan does not replace direct assessment. Protective factors must be considered alongside current intent and access.
NIMH — Adult Outpatient Brief Suicide Safety Assessment Guide
26.When does polysomnography strengthen a Lewy body assessment?
Dream enactment suggests REM sleep behavior disorder but can be mimicked by other sleep problems. Polysomnographic demonstration of REM sleep without atonia is an indicative biomarker in the dementia with Lewy bodies criteria. The test therefore has a specific diagnostic role when the sleep history is uncertain or requires confirmation. Interpret the result within the clinical syndrome; polysomnography is not a general screening test that independently establishes the cause of every cognitive complaint.
Apply it
A partner describes punching and shouting during dreams in a patient with dementia. Because obstructive sleep apnea and other events can resemble dream enactment, sleep evaluation can clarify whether REM sleep without atonia is present.
Common pitfall: A report of restless sleep is not equivalent to confirmed REM sleep behavior disorder. Establish the event characteristics and consider mimics before applying biomarker-based diagnostic rules.
Diagnosis and Management of Dementia with Lewy Bodies: Fourth Consensus Report
27.How should a lithium concentration be timed and interpreted?
For routine monitoring, the cited lithium product label specifies sampling approximately 12 hours after the previous dose, immediately before the next dose under that monitoring arrangement. Document both dosing and sampling times. Interpret the result with symptoms, adherence, renal function, hydration, and interacting medicines; a sample obtained soon after dosing is not interchangeable with the intended monitoring concentration. Suspected toxicity requires immediate clinical and laboratory assessment and must not wait for a scheduled 12-hour sample. Clinical toxicity can occur at concentrations otherwise tolerated by other patients.
Apply it
An asymptomatic patient takes lithium immediately before a routine blood draw. Verify the actual dosing and sampling times and arrange an interpretable measurement. A different patient with new ataxia and confusion needs urgent assessment immediately, regardless of the routine sampling schedule.
Common pitfall: Neither a mistimed result nor an apparently reassuring concentration should determine management alone. Routine monitoring instructions must not delay evaluation of a concerning clinical syndrome.
DailyMed — Lithium Carbonate Capsules Prescribing Information
28.How does a medication timeline improve psychiatric diagnosis?
A medication timeline links symptom onset with initiation, dose changes, missed doses, discontinuation, and interactions. Include nonpsychiatric prescriptions and nonprescription products, because corticosteroids and anticholinergic agents can produce clinically important psychiatric effects. Temporal association supports a causal hypothesis but does not prove it; compare alternative explanations, attention, baseline symptoms, and the course after coordinated changes. This approach distinguishes adverse effects, withdrawal, and primary illness more reliably than reviewing only the current medication list.
Apply it
A patient's new insomnia and suspiciousness began after prednisone was increased, while a sleep aid was added several days later. Reconstructing that order prevents incorrectly blaming the later medicine for the initial syndrome.
Common pitfall: The most recently noticed medicine is not necessarily the cause. Review actual start dates, dose changes, discontinuations, and nonprescription exposure before drawing conclusions.
DailyMed — Prednisone Delayed-Release Tablets Prescribing Information · American Geriatrics Society 2023 Updated AGS Beers Criteria
29.How should diagnostic testing be directed in suspected delirium?
Testing for delirium should seek likely precipitants identified through history, medication review, physical assessment, and the pattern of acute change. Infection, metabolic disturbance, dehydration, medication effects, intoxication, and withdrawal are important possibilities. There is no single laboratory result that establishes all causes of delirium. The diagnostic task is to identify and treat the underlying contributors while recognizing that more than one may be operating, especially in a medically vulnerable older adult.
Apply it
An older patient develops fluctuating inattention after poor intake and several medication changes. Assessment should examine hydration, physiological disturbance, and drug effects together rather than selecting one explanation before reviewing the clinical evidence.
Common pitfall: Finding one abnormal result does not prove it caused the mental-state change. Interpret abnormalities in context and continue considering additional clinically plausible contributors.
30.What can an anxiety rating scale establish?
A symptom scale can structure assessment and track change, but a score does not replace a clinical diagnosis. For generalized anxiety disorder, the interview must establish the duration, breadth, controllability, associated symptoms, impairment, and possible medical or medication explanations. Repeated measurement is most useful when connected to the same treatment goals and clinical context. A change in score should be interpreted alongside functioning and adverse effects rather than treated as a complete account of recovery.
Apply it
A patient's anxiety score improves, but the patient still avoids necessary appointments and reports medication-related dizziness. Review those functional and safety outcomes before concluding that treatment has achieved its goals.
Common pitfall: Screening thresholds are not self-sufficient diagnostic criteria. Physical symptoms from illness or medicines may influence scores and require interpretation rather than automatic psychiatric labeling.
NIMH — Generalized Anxiety Disorder: What You Need to Know · Geriatric Psychiatry Certification Content Specifications
E. Treatment31-35%
5.How does renal handling explain lithium accumulation?
Lithium is eliminated primarily through the kidneys, making renal function, sodium balance, hydration, and interacting medicines central to its pharmacokinetics. Dehydration, sodium depletion, or reduced clearance can increase lithium concentrations without any change in the prescribed dose. Older adults may have less physiological reserve for these changes. A new tremor, ataxia, gastrointestinal upset, or confusion therefore requires consideration of toxicity rather than automatic attribution to aging or the underlying mood disorder.
Apply it
A patient taking a stable lithium dose develops diarrhea and poor intake during an illness, followed by unsteadiness. The unchanged prescription does not establish safety; altered hydration and renal handling can increase exposure.
Common pitfall: A previously therapeutic concentration does not protect against a new interaction or acute illness. Assess the current clinical state, renal function, and medication exposures.
DailyMed — Lithium Carbonate Capsules Prescribing Information · Geriatric Psychiatry Certification Content Specifications
31.How does supportive care help a patient with delirium?
Delirium care combines treatment of underlying causes with measures that reduce disorientation and physiological stress. Familiar people, clear communication, appropriate sensory aids, sleep support, hydration, nutrition, and a calm environment can help the patient function more safely. These measures address vulnerabilities that medicines alone cannot correct. Management should be individualized to medical status and immediate risks, with repeated assessment because both attention and behavior can fluctuate substantially during the same day.
Apply it
A confused inpatient lacks hearing aids, sleeps poorly, and drinks little. Restoring hearing support, improving orientation, and addressing intake complement medical evaluation rather than waiting for agitation to become the sole treatment target.
Common pitfall: Sedating a patient does not correct the cause of delirium. A quieter appearance can conceal persistent inattention, worsening medical illness, or medication-related adverse effects.
32.When are cholinesterase inhibitors relevant in Lewy body dementia?
The Lewy body consensus report supports cholinesterase inhibitors such as rivastigmine and donepezil for cognitive and global clinical outcomes in dementia with Lewy bodies. These agents may also improve hallucinations and delusions, making them relevant when cognitive and neuropsychiatric symptoms coexist. Treatment selection requires attention to tolerability and patient goals. The decision is broader than suppressing one symptom: assess whether cognition, daily function, behavior, and caregiver experience improve over time.
Apply it
A patient with Lewy body dementia has declining attention and recurrent nonthreatening hallucinations. Discussing a cholinesterase inhibitor addresses the broader syndrome before exposing the patient to an antipsychotic solely because hallucinations are present.
Common pitfall: These medicines are not guaranteed to stop hallucinations or reverse the disease. Monitor benefit and adverse effects rather than continuing treatment solely because its mechanism seems appropriate.
Diagnosis and Management of Dementia with Lewy Bodies: Fourth Consensus Report
33.Why require a high threshold for antipsychotics in dementia?
Antipsychotics in dementia are associated with important harms, including increased stroke risk, cognitive decline, and mortality. The Beers Criteria recommend avoiding them for dementia-related behavior or delirium unless nonpharmacologic options have failed or are not possible and substantial harm is threatened. Dementia with Lewy bodies adds concern for serious sensitivity reactions. Define the target symptom, investigate reversible causes, weigh benefits and harms, and periodically reassess whether a continued prescription remains justified.
Apply it
A patient with dementia reports a harmless visual visitor without distress or dangerous behavior. Investigate causes and provide support rather than automatically prescribing an antipsychotic to eliminate the experience.
Common pitfall: Atypical antipsychotics are not free of dementia-related mortality risk. Apparent sedation should not be mistaken for meaningful improvement in distress, safety, or function.
American Geriatrics Society 2023 Updated AGS Beers Criteria · Diagnosis and Management of Dementia with Lewy Bodies: Fourth Consensus Report
34.How should cumulative anticholinergic burden guide prescribing?
Anticholinergic effects accumulate across medicines, so several modest exposures can create a clinically important burden. Older adults are vulnerable to confusion, constipation, urinary retention, and other adverse effects; cumulative exposure is also associated with falls and delirium. Review prescription and nonprescription drugs together, including sedating antihistamines and strongly anticholinergic antidepressants. A useful intervention is to remove unnecessary contributors or choose safer alternatives rather than adding medicines to treat each adverse effect separately.
Apply it
An older adult develops constipation and confusion while taking a bladder antimuscarinic and nightly diphenhydramine. Reviewing both agents offers a more coherent response than adding a laxative and a cognitive medicine without reassessing exposure.
Common pitfall: Counting only psychiatric prescriptions misses common contributors. Over-the-counter availability and long-standing use do not establish that an anticholinergic medicine remains appropriate for an older patient.
35.How should established primary psychosis be treated in an older adult?
For established schizophrenia, use an antipsychotic with psychosocial treatment and continue effective medication to reduce relapse. Choose according to prior response, adverse effects, comorbidity, interactions, and preference. Monitor weight, glucose, lipids, orthostatic blood pressure, sedation, falls, and abnormal movements. An oral agent permits assessment of response and tolerability; a long-acting injectable is reasonable when preferred or adherence is poor or uncertain. Persistent symptoms require verification of adequate dose, duration, and adherence before declaring resistance. Clozapine is indicated for treatment-resistant illness and can address substantial persistent suicide risk, but requires ANC monitoring and active assessment for myocarditis, orthostasis, and potentially severe gastrointestinal hypomotility. These distinctions are supported by the [APA schizophrenia recommendations](https://www.psychiatry.org/news-room/news-releases/apa-releases-new-practice-guideline-on-treatment-o) and [clozapine prescribing information](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=0fa59238-f0a6-4d00-9d8d-df2a43718fc1&type=display).
Apply it
An older patient repeatedly relapses after missed oral antipsychotic doses but improves when treatment is taken. Discuss a suitable long-acting formulation rather than assuming pharmacological resistance. Persistent psychosis despite two adequate, adherent antipsychotic trials instead supports evaluating clozapine.
Common pitfall: Dementia-related antipsychotic cautions do not justify leaving established schizophrenia untreated. Clozapine is not a routine response to one poorly tolerated or inadequately taken trial, and constipation during treatment requires active assessment.
Psychiatry.org - What is Schizophrenia? · American Geriatrics Society 2023 Updated AGS Beers Criteria
36.Why are benzodiazepines used for significant alcohol withdrawal?
Benzodiazepines are first-line pharmacotherapy for alcohol withdrawal because they reduce withdrawal symptoms and the risk of seizures and delirium. This is a specific indication in which their benefits can outweigh age-related risks. Selection and monitoring should account for liver function, oversedation, respiratory status, concurrent depressants, and withdrawal severity. An antipsychotic may sometimes be an adjunct for inadequately controlled symptoms, but it does not replace adequate medication directed at the withdrawal process.
Apply it
An older patient has escalating tremor, tachycardia, and hallucinations during alcohol withdrawal. Monitored benzodiazepine-based treatment addresses the withdrawal syndrome; treating hallucinations with an antipsychotic alone would leave seizure and delirium risk insufficiently addressed.
Common pitfall: General cautions about benzodiazepines in older adults should not lead to withholding effective treatment for dangerous withdrawal. Indication, setting, monitoring, and reassessment determine appropriate use.
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
37.When should thiamine accompany alcohol withdrawal care?
Thiamine is recommended during alcohol withdrawal management to prevent Wernicke encephalopathy, with parenteral administration preferred in patients with poor nutritional status, malabsorption, or severe complications. Nutritional and electrolyte problems require attention alongside control of withdrawal. ASAM permits thiamine and glucose to be given in either order or concurrently, so urgent glucose treatment should not be delayed. The decision concerns comprehensive medical stabilization rather than assuming a sedative regimen addresses every alcohol-related neurological risk.
Apply it
A malnourished patient undergoing withdrawal also has hypoglycemia. Give necessary glucose promptly and provide thiamine as part of coordinated medical care rather than delaying glucose while waiting for thiamine to arrive.
Common pitfall: A rigid rule that glucose must always wait for thiamine can delay treatment of hypoglycemia. Prevention of thiamine deficiency remains essential during stabilization.
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
38.How should alcohol relapse-prevention medication be selected after withdrawal?
Withdrawal management must lead to ongoing alcohol use disorder treatment. Naltrexone, an opioid antagonist, can reduce return to heavy drinking; current opioid analgesic use or opioid dependence precludes starting it because it blocks analgesia and can precipitate withdrawal. Assess hepatic status and monitor for liver injury and nausea. Acamprosate supports maintenance of abstinence after withdrawal and is useful when avoiding hepatic metabolism is desirable, but requires renal assessment: creatinine clearance of 30–50 mL/min requires dose reduction, and 30 mL/min or less is a contraindication. Diarrhea and a three-times-daily regimen can limit tolerability or adherence. Disulfiram deters drinking through acetaldehyde accumulation; reserve it for a fully informed patient pursuing abstinence with reliable adherence support. Severe myocardial disease and psychosis are contraindications, and hepatic injury, neuropathy, and a dangerous alcohol reaction are important concerns. Compare the [naltrexone label](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=f821dd49-3fa7-4d33-99de-19023ff1ae65&type=display), [acamprosate label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43e9ef60-2d85-4394-906b-93042fea099a), and [disulfiram label](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=35f34124-7300-4b96-911f-d9f03016ea14).
Apply it
An abstinent older adult taking an opioid for cancer pain cannot simply start naltrexone. Acamprosate may be reasonable if renal function permits and the regimen is manageable. A patient with severe renal impairment instead needs another approach; disulfiram is a poor alternative when severe cardiac disease, psychosis, or inability to understand the alcohol reaction is present.
Common pitfall: These medicines do not replace acute withdrawal treatment or psychosocial care. Older-adult selection depends on actual opioid exposure, kidney and liver function, cognition, cardiac risk, adherence, and goals rather than age alone.
ASAM — Alcohol Withdrawal Management Guideline · Geriatric Psychiatry Certification Content Specifications
39.How should a long-term benzodiazepine taper be individualized?
A benzodiazepine taper should be gradual, collaborative, and adjusted to the patient's response, exposure history, comorbidity, and withdrawal risk. Abrupt discontinuation after sustained use can produce serious withdrawal, including seizures. Smaller reductions, pauses, and a slower pace may be needed when symptoms emerge, particularly in older adults. The goal is to reduce medication-related harm without creating avoidable withdrawal, while treating the original anxiety or sleep problem through appropriate alternatives and ongoing support.
Apply it
A patient develops marked tremor and insomnia after an initial reduction in a long-standing prescription. Reassess for withdrawal and consider slowing or pausing the taper rather than enforcing an unchanged schedule despite worsening symptoms.
Common pitfall: One schedule does not fit every patient. Automatically switching every older adult to a long-acting benzodiazepine may introduce accumulation concerns and requires individualized judgment.
Joint Clinical Practice Guideline on Benzodiazepine Tapering, 2025
40.How should an antidepressant be selected for an older adult with unipolar depression?
Match treatment to previous response, symptom burden, medical conditions, interactions, adverse-effect vulnerability, cost, and preference. An SSRI with relatively low anticholinergic burden, such as sertraline, can be a reasonable option; paroxetine and strongly anticholinergic tricyclics are generally poor routine choices in older adults. Mirtazapine's sedation and appetite or weight effects may be useful when those symptoms are treatment targets but may be undesirable with daytime sleepiness or fall risk. Bupropion is less suitable when seizure risk is important. Screen for bipolar history before prescribing, and titrate according to tolerability and response rather than leaving treatment indefinitely at an ineffective starting dose.
Apply it
A patient with depression, constipation, cognitive vulnerability, and several anticholinergic medicines needs treatment. A lower-anticholinergic option with interaction review is preferable to adding paroxetine merely because it helped a relative.
Common pitfall: No antidepressant is uniformly best for older adults. An apparently useful sedating or appetite-promoting effect must still be weighed against daytime impairment and other harms.
American Geriatrics Society 2023 Updated AGS Beers Criteria · mdd.pdf · Psychiatry.org - What Is Depression?
41.What should routine antidepressant follow-up monitor?
Follow mood symptoms, suicide risk, functioning, adherence, adverse effects, and activation suggesting a switch to mania. SSRIs, SNRIs, mirtazapine, and tricyclics can cause or worsen SIADH or hyponatremia; the Beers Criteria advise close sodium monitoring when starting or changing doses in older adults. Assess dizziness, gait and falls, gastrointestinal effects, sleep, and interactions. Benefits develop over weeks, so assess actual dose and duration before declaring nonresponse. New confusion or unsteadiness after initiation requires evaluation for harm rather than automatic dose escalation. After improvement, continuation treatment reduces relapse risk; withdrawal should be planned rather than abrupt.
Apply it
An older adult taking a diuretic develops new confusion and gait instability after starting an SSRI. Check sodium and other medical causes promptly while reviewing the treatment timeline, rather than interpreting the change as worsening depression.
Common pitfall: An improved symptom score does not establish tolerability or restored function. Conversely, a brief low-dose exposure does not establish treatment resistance.
American Geriatrics Society 2023 Updated AGS Beers Criteria · Psychiatry.org - What Is Depression? · mdd.pdf
42.When do symptoms during lithium treatment require urgent action?
New vomiting, diarrhea, worsening tremor, ataxia, confusion, or other neurological changes during lithium treatment can signal toxicity, particularly after dehydration, illness, or an interacting medicine. Suspected toxicity warrants withholding lithium and prompt medical assessment, including concentration and renal evaluation, rather than routine follow-up alone. Management depends on clinical severity and exposure. Patient counseling should connect these warning signs to a clear action plan, because early symptoms may otherwise be mistaken for a minor infection or normal aging.
Apply it
After several days of poor intake, a lithium-treated patient becomes confused and walks unsteadily. Withhold further lithium and obtain urgent medical evaluation rather than waiting for the next scheduled monitoring visit.
Common pitfall: Waiting for a concentration before responding to a concerning clinical syndrome can delay care. A familiar maintenance prescription does not exclude acute toxicity during intercurrent illness.
DailyMed — Lithium Carbonate Capsules Prescribing Information
43.How should acute bipolar mania treatment be selected in an older adult?
Acute mania requires assessment of safety, intake, sleep, psychosis, exposures, and need for hospitalization. Lithium treats acute mania and provides maintenance benefit when renal handling and monitoring are suitable. Assess renal function, electrolytes, thyroid function, hydration, and interacting medicines before treatment; severe renal impairment makes lithium unsuitable. Quetiapine is an alternative for acute bipolar I mania and can be combined with lithium when indicated, but somnolence, orthostatic hypotension, falls, constipation, and metabolic effects may limit its use. Older adults require slower titration and careful monitoring. Monitor response through mood, energy, sleep, judgment, psychosis, and function, rather than sedation alone. The [quetiapine prescribing information](https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d77412a-e084-4406-ac33-d882aece9354) distinguishes its acute and maintenance indications.
Apply it
An older adult with severe mania and psychosis needs rapid stabilization. Renal impairment, dehydration, and interacting antihypertensives weigh against lithium until assessed and corrected where possible. An antipsychotic can address mania and psychosis, but prominent orthostasis or falls requires cautious selection and titration.
Common pitfall: A sedative response does not establish control of mania. Lamotrigine is not an acute antimanic treatment, and antidepressant monotherapy is inappropriate for an active manic episode.
Psychiatry.org - What Are Bipolar Disorders? · DailyMed — Lithium Carbonate Capsules Prescribing Information · American Geriatrics Society 2023 Updated AGS Beers Criteria
44.When should ECT enter treatment planning for depression?
Electroconvulsive therapy is an important option for severe depression when a rapid response is needed, when other treatments have failed, or when severe symptoms such as psychosis or catatonia are present. It is administered under anesthesia after medical evaluation. The decision weighs urgency, previous treatment, medical status, preferences, and cognitive risks. Explain temporary confusion and memory difficulties, including that some memory effects can persist, and assess cognition during treatment. ECT should enter discussion early enough to address a dangerous clinical trajectory rather than being reserved automatically until every conceivable medication sequence has been attempted.
Apply it
An older adult with severe psychotic depression is barely eating and deteriorating medically. ECT deserves prompt consideration because the need for effective treatment is urgent, even if a lengthy series of medication trials is incomplete. Discuss memory concerns, baseline cognition, and continuing treatment alongside medical and anesthetic evaluation.
Common pitfall: ECT is not restricted to medication-resistant illness. Conversely, severity alone does not remove the need for medical evaluation, informed consent, cognitive-risk counseling, and a continuing treatment plan.
American Psychiatric Association — Electroconvulsive Therapy
45.How do bipolar depression and maintenance treatment differ from acute antimanic treatment?
Match the medicine to the phase. Quetiapine has an indication for acute bipolar depression; monitor sedation, orthostasis, weight, glucose, and lipids. Lithium provides ongoing prevention when effective and medically suitable, with concentration, renal, and thyroid monitoring. Lamotrigine has a bipolar I maintenance indication after acute stabilization; its label does not establish acute mood-episode efficacy and does not recommend it for acute mania. It requires slow titration because rapid escalation increases serious-rash risk, particularly with valproate. A new rash warrants prompt assessment and discontinuation unless clearly unrelated. Avoid treating bipolar I depression with antidepressant monotherapy because of switching risk. Severe depression with urgent nutritional or suicide concerns may warrant ECT. Compare the [quetiapine label](https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d77412a-e084-4406-ac33-d882aece9354) and [lamotrigine label](https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7e3572d-56fe-4727-2bb4-013ccca22678).
Apply it
For acute bipolar depression, quetiapine may address the current episode but daytime somnolence and falls can alter the balance. After stabilization, a patient for whom lithium is medically unsuitable may be considered for lamotrigine maintenance, with explicit slow-titration and rash instructions rather than an expectation of rapid antimanic action.
Common pitfall: Efficacy in one phase does not establish efficacy in every phase. Do not restart a substantially interrupted lamotrigine regimen at the old full dose without assessing the need for retitration, and do not stop preventive treatment simply because mood has normalized.
Psychiatry.org - What Are Bipolar Disorders? · DailyMed — Lithium Carbonate Capsules Prescribing Information · American Psychiatric Association — Electroconvulsive Therapy
46.How can psychotherapy fit late-life depression treatment?
Psychotherapy can treat depression by addressing patterns of thinking, behavior, coping, and relationships, and it can be used alone or with medication depending on severity and need. Cognitive behavioral therapy is one established approach. Selection should account for the patient's goals, preferences, accessibility, cognitive abilities, and clinical urgency. A psychotherapy plan is an active treatment with defined targets and follow-up, rather than reassurance alone or a reason to delay more urgent intervention in severe illness.
Apply it
A patient with depression has withdrawn from enjoyable activities and repeatedly interprets minor setbacks as personal failure. A structured psychotherapy plan can target those patterns while monitoring mood, functioning, and any need for additional treatment.
Common pitfall: Assuming older adults cannot benefit from psychotherapy confuses age with ability. The opposite error is relying on routine sessions alone during an immediate suicide or nutritional crisis.
47.Why is CBT a useful treatment for generalized anxiety disorder?
Cognitive behavioral therapy helps patients identify and change thinking and behavioral patterns that sustain anxiety. For generalized anxiety disorder, it offers practical ways to respond to worry rather than depending only on reassurance or rapid sedation. Treatment may be used with medication when appropriate. Explain that antidepressant benefits take time, whereas benzodiazepines act quickly but carry dependence and other safety concerns, making an immediate calming effect an incomplete basis for long-term treatment selection.
Apply it
An older adult requests a daily sedative for chronic worry but has experienced falls. Discuss CBT and appropriate longer-term treatment options while explaining why immediate relief must be weighed against sedation, dependence, and functional risk.
Common pitfall: A preference for quick relief does not mean the patient rejects psychotherapy. Explain its practical tasks and expected role rather than offering it as a vague instruction to relax.
NIMH — Generalized Anxiety Disorder: What You Need to Know · American Geriatrics Society 2023 Updated AGS Beers Criteria
48.How should treatment engage a patient with hoarding disorder?
Treatment for hoarding disorder commonly uses specialized cognitive behavioral approaches that address acquiring, sorting, discarding, decision-making, and beliefs about possessions. Engagement improves when goals connect with the patient's priorities and concrete safety needs. Family education can reduce conflict and support change. A plan should distinguish immediate hazards from the longer process of modifying behavior, because removing possessions without addressing the underlying difficulty does not establish a durable therapeutic response.
Apply it
A patient wants a grandchild to visit but cannot use the sitting room. Link treatment to restoring safe shared space and work collaboratively on sorting and discarding rather than beginning with an argument about every possession.
Common pitfall: A forced cleanout may provoke distress and does not teach the skills needed to prevent recurrence. Immediate safety concerns still require proportionate action and coordinated planning.
49.Which treatment targets prolonged grief rather than ordinary remembrance?
Psychotherapy for prolonged grief disorder addresses persistent separation distress, adaptation to the loss, and restoration of meaningful engagement in life. The aim is not to eliminate memories or require detachment from the deceased. Treatment can help patients process the death and rebuild functioning while preserving an enduring connection. Assess co-occurring depression separately, since a medication appropriate for depression does not by itself constitute a grief-focused intervention for the full prolonged grief syndrome.
Apply it
A patient fears that resuming friendships would betray a deceased spouse. Grief-focused therapy can address this meaning and support renewed engagement while respecting the continuing importance of the relationship.
Common pitfall: Medication for depressive symptoms should not be presented as a proven replacement for grief-focused psychotherapy. Continued remembrance alone is not a treatment failure or a diagnostic symptom.
50.What belongs in a practical suicide safety plan?
A safety plan identifies warning signs, coping strategies, supportive people, professional contacts, and steps to reduce access to lethal means. It should be specific enough for the patient to use during worsening distress and developed collaboratively when the patient can participate. Current suicidal thoughts require urgent evaluation rather than reliance on outpatient planning alone. A promise not to self-harm is not an equivalent intervention because it does not create practical coping steps or reduce access to dangerous methods.
Apply it
A patient without current suicidal intent agrees to a plan naming early warning signs, a trusted contact, crisis resources, and secure medication storage. Confirm that the steps are feasible and understood rather than merely handing over a form.
Common pitfall: A signed agreement cannot establish safety. A detailed plan also does not override current intent, accessible means, or other findings that require immediate emergency evaluation.
NIMH — Adult Outpatient Brief Suicide Safety Assessment Guide
F. Interpersonal and communication skills1-3%
51.How does teach-back reveal whether instructions were understood?
Teach-back asks the patient to explain important information in their own words so the clinician can assess how clearly it was communicated. Frame it as a check of the explanation rather than a test of the patient. If the response reveals confusion, clarify the message and ask again. This method is particularly useful for medication changes and warning signs because agreement, nodding, or saying that everything is understood does not demonstrate usable understanding.
Apply it
After explaining a medication change, ask, 'To check that I explained it clearly, how will you take this when you get home?' The patient's description reveals that the discontinued tablet would otherwise have been continued.
Common pitfall: Asking 'Do you understand?' invites a yes without demonstrating comprehension. Repeating the same jargon more loudly also fails to address the source of misunderstanding.
G. Professionalism, ethics, and the law2-4%
52.What must be assessed for meaningful informed consent?
Assess four decision-making abilities: understanding relevant information; appreciating how the condition, options, and consequences apply personally; reasoning between options; and communicating a choice. Consent also requires relevant disclosure, an opportunity for questions, and freedom from coercion. Discuss benefits, burdens, alternatives, and forgoing treatment. Capacity is specific to the decision and circumstances; a psychiatric or cognitive diagnosis alone does not determine it. Support hearing, language, comprehension, and attention, address reversible barriers, and document the patient's actual demonstration of each ability rather than relying on a signature or accurate repetition.
Apply it
One patient accurately repeats that untreated infection can be fatal but insists the diagnosis and consequences cannot apply personally because of a delusion; appreciation is impaired despite factual recall. Another recognizes the infection and personal risks, compares treatment burdens with likely outcomes, explains a coherent decision based on personal values, and communicates a voluntary choice. Disagreement with the clinician does not invalidate the latter decision.
Common pitfall: Accurate repetition and a consistent choice do not establish appreciation or reasoning. Mild cognitive impairment does not automatically remove capacity, and choosing the recommended treatment does not itself prove capacity.
AMA Code of Medical Ethics — Informed Consent · Resource-Document-2019-Decisional-Capacity-Determinations-in-Consultation-Liaison-Psychiatry.pdf
53.When can an emergency justify treatment without prior consent?
Under AMA Opinion 5.2, Advance Directives, urgently necessary, medically appropriate treatment may proceed when the patient cannot participate and neither an available surrogate nor an applicable advance directive can guide the immediate decision. Check available directives, determine whether their clinical conditions are met, and honor known treatment limitations. Urgency and an unreachable surrogate do not erase the patient's preferences. Limit intervention to immediate clinical needs, document the circumstances, and explain treatment and obtain consent for continuing care as soon as possible. A capable patient's current wishes take precedence over an advance directive.
Apply it
A patient with severe confusion develops an immediately life-threatening condition and cannot participate in decisions. A rapid check of available records finds no advance directive or documented treatment limitation, and no surrogate can be reached in time. Necessary stabilization may proceed while contact efforts continue. If an applicable directive instead prohibits the proposed intervention, honor that limitation and provide appropriate permitted care.
Common pitfall: Incapacity alone does not authorize treatment without consent. Neither disagreement nor an inconvenient consent process establishes the emergency exception. An available directive must be assessed for applicability rather than ignored because the situation is urgent. If preferences become known after stabilization, reassess ongoing interventions; AMA Opinion 5.2 permits withdrawal consistent with those preferences and ethical guidance.
AMA Code of Medical Ethics — Informed Consent · Advance Directives | AMA Code of Medical Ethics
H. Practice-based learning and improvement1-3%
54.How should evidence uncertainty influence a treatment decision?
Interpret evidence using effect size, confidence intervals, study limitations, relevance, and patient priorities rather than a statistical significance label alone. A confidence interval crossing no effect can remain compatible with meaningful benefit and harm, particularly in a small study. Conversely, a statistically detectable difference may be too small to matter clinically. Translate results into absolute effects when possible and judge whether the population, comparator, outcomes, and follow-up answer the patient's actual treatment question.
Apply it
A small trial reports a modest benefit with an interval spanning possible harm and substantial benefit. Describe the uncertainty and examine relevance rather than claiming either proven efficacy or proof that the treatments are identical.
Common pitfall: Failure to reach statistical significance does not demonstrate equivalence. A precise estimate also does not solve problems of bias, indirectness, or outcomes that matter little to patients.
Cochrane Handbook — Chapter 15: Interpreting Results and Drawing Conclusions
I. Systems-based practice8-12%
55.How does collaborative care organize depression treatment?
Collaborative care integrates behavioral health treatment into primary care through structured teamwork. A care manager supports follow-up and symptom monitoring, the primary clinician provides treatment, and a psychiatric consultant reviews care and recommends adjustments. Systematic tracking helps identify patients who are not improving rather than relying on unscheduled contact. The distinguishing feature is an organized treatment process with shared responsibilities and follow-through, not simply locating a mental health clinician in the same building.
Apply it
A primary care practice tracks depression outcomes, has a care manager contact patients, and reviews nonresponding cases with a psychiatric consultant. This structure supports treatment adjustment even when the psychiatrist does not personally see every patient.
Common pitfall: Sending a referral without tracking whether treatment occurs is not the same as collaborative care. Co-location alone does not establish shared monitoring or systematic consultation.
American Psychiatric Association — Integrated Behavioral Healthcare
56.How should care respond to treatment nonadherence?
Nonadherence to medical treatment is a condition that may be a focus of clinical attention, rather than automatically a new mental disorder. Identify the specific barrier before choosing an intervention: misunderstanding, cost, adverse effects, access, preferences, and practical difficulties imply different responses. Confirm the patient's account and use a shared plan. An intervention should solve the demonstrated obstacle rather than applying a moral label or assuming that more education will correct an affordability problem.
Apply it
A patient understands an antidepressant plan but cannot afford the prescription and has stopped filling it. Address cost and access with the care team rather than documenting poor motivation or repeating the same instructions.
Common pitfall: The word nonadherent describes a treatment problem without explaining its cause. Do not infer cognitive impairment, intentional resistance, or a psychiatric diagnosis without supporting evidence.
American Psychiatric Association — DSM-5-TR Update, September 2024, with Previous Updates · AHRQ — Tool: Teach-Back
57.Why is medication reconciliation important during care transitions?
Transitions between hospital, home, and residential care can leave inconsistent medication lists, duplicated therapies, or unclear instructions. Reconcile what was intended with what the patient actually takes, including nonprescription products, and communicate the resulting plan to relevant clinicians. In older adults, preventable anticholinergic and sedative exposure can have substantial consequences. Teach-back verifies whether the patient can implement the plan, making reconciliation a practical safety process rather than merely copying a list into another document.
Apply it
After discharge, a patient continues an old sleep medicine while taking its replacement and an over-the-counter antihistamine. Comparing actual bottles with the intended plan identifies duplication that the discharge list alone failed to reveal.
Common pitfall: An apparently complete list may still be inaccurate. Confirm actual use, discontinued medicines, and nonprescription exposure instead of assuming every documented drug is currently taken as intended.
American Geriatrics Society 2023 Updated AGS Beers Criteria · AHRQ — Tool: Teach-Back
58.How should a team review medication-related fall risk?
Fall risk can reflect cumulative exposure to several central nervous system medicines rather than one clearly inappropriate drug. The Beers Criteria highlight increased falls and fractures with combinations of three or more CNS-active agents from specified classes. Coordinate review across prescribers, confirm each indication, and consider whether benefits justify combined effects. Reducing unnecessary exposure requires a shared plan, particularly when dependence or symptom recurrence makes abrupt discontinuation inappropriate for an individual medicine.
Apply it
A patient taking an antidepressant, benzodiazepine, and opioid reports repeated falls. A coordinated review should examine the combination and each indication rather than asking three clinicians independently whether their own prescription is necessary.
Common pitfall: Finding a potentially risky combination does not authorize abrupt discontinuation of every agent. Address withdrawal, pain, mood symptoms, and the patient's priorities through coordinated changes.
59.How should community care respond to progressive loss of independence from a neurocognitive disorder?
Translate cognitive and behavioral findings into a shared plan for actual daily needs: medication administration, finances, meals, transport, communication, and supervision. Identify which tasks the patient can still perform and which require support, then coordinate family, primary care, specialist, and community services with clear responsibilities. Changes in behavior require assessment of medical illness, pain, medication effects, and environmental triggers before adding sedating treatment. Preserve the patient's participation in decisions to the extent possible, and reassess support needs as function changes.
Apply it
A patient with progressive cognitive impairment repeatedly misses medicines despite understanding simple instructions. The team arranges reliable medication assistance and follow-up rather than repeatedly providing the same written schedule or assuming that a diagnostic label alone determines residential placement.
Common pitfall: Naming a dementia subtype does not create a workable care plan. Family availability should be established directly, and cognitive impairment alone does not eliminate the patient's role in decisions.
Geriatric Psychiatry Certification Content Specifications · American Geriatrics Society 2023 Updated AGS Beers Criteria · AMA Code of Medical Ethics — Informed Consent
60.Which factors determine the setting for alcohol withdrawal care?
Withdrawal setting depends on more than current symptoms: previous complicated withdrawal, age, medical and psychiatric instability, concurrent substance use, available support, and capacity for reliable monitoring all matter. Ambulatory management requires a safe environment and a workable reassessment plan. Escalating symptoms, confusion, oversedation, or unstable medical findings can require transfer to a more intensive setting. Match resources to anticipated risk rather than assuming that a low initial symptom score establishes suitability for home treatment.
Apply it
An older adult has modest withdrawal symptoms but lives alone, has unstable medical illness, and previously experienced withdrawal delirium. These factors argue for a more supported setting despite the initially limited tremor and anxiety.
Common pitfall: Age alone is not the entire placement decision, and a symptom scale alone is equally incomplete. Integrate clinical risk, environment, monitoring, and ability to transfer promptly.
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give the largest study block to treatment: connect each intervention with its indication, older-adult risks, monitoring, and a reason to continue or change it.
- Practise chronology-based differentials: acute delirium versus progressive cognitive change, grief versus depression, and primary illness versus medication or withdrawal effects.
- Use both blueprint dimensions. For example, study alcohol withdrawal as mechanism, presentation, treatment, and care-setting selection rather than as one isolated diagnosis.
- Compare Alzheimer, vascular, frontotemporal, and Lewy body presentations using onset, cognitive profile, behavior, neurological findings, function, and evidence for mixed etiologies.
- Establish complete depressive, manic, hypomanic, and anxiety criteria; distinguish schizophrenia-spectrum disorders through duration and the proportion of illness occupied by major mood episodes.
- Compare acute mania, bipolar depression, maintenance treatment, established primary psychosis treatment, and alcohol relapse-prevention medicines by indication, contraindications, adverse effects, and monitoring.
- Treat nonadherence, affordability, family communication, and care transitions as substantive clinical problems with specific interventions.
- Use the complete official outline to review smaller categories, including neurodevelopmental, dissociative, eating, sexual, gender-related, personality, paraphilic, and forensic topics that this selective guide does not comprehensively teach.
A practical preparation plan
1. Build a two-dimensional coverage map
List the nine competency domains beside the official disorder categories. Mark whether each study session addressed mechanism, diagnosis, treatment, or systems issues, and use the official weight ranges to direct effort without adding the two dimensions together.
2. Reconstruct the timeline before naming the disorder
For each case, identify baseline function, onset, fluctuation, medication changes, substance exposure, and functional consequences. Write the finding that most strongly separates the leading diagnosis from its closest alternative.
3. Explain treatment through benefit and harm
For each intervention, state its target, expected benefit, important older-adult risk, monitoring plan, and alternative. Rehearse why a general prescribing caution may have a valid exception, as with benzodiazepines for alcohol withdrawal.
4. Complete and analyze the independent drills
Answer the 20 questions before reading explanations. For every error, identify whether the problem was missed chronology, incomplete criteria, medication safety, evidence interpretation, or care coordination, then restudy the corresponding concept.
5. Use active recall and close scope gaps
Answer flashcards aloud with the discriminating reason. Return to the full official outline for topics absent from the cards and use the official demonstration examination to become familiar with the computer interface.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ABPN — Geriatric Psychiatry: Initial Certification
- Geriatric Psychiatry Certification Content Specifications
- Geriatric Psychiatry Certification Format and Scoring
- MedlinePlus — Delirium
- Diagnosis and Management of Dementia with Lewy Bodies: Fourth Consensus Report
- American Geriatrics Society 2023 Updated AGS Beers Criteria
- The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management
- ASAM — Alcohol Withdrawal Management Guideline
- Joint Clinical Practice Guideline on Benzodiazepine Tapering, 2025
- DailyMed — Prednisone Delayed-Release Tablets Prescribing Information
- American Psychiatric Association — Electroconvulsive Therapy
- NIMH — Adult Outpatient Brief Suicide Safety Assessment Guide
- DailyMed — Lithium Carbonate Capsules Prescribing Information
- NIMH — Generalized Anxiety Disorder: What You Need to Know
- American Psychiatric Association — Hoarding Disorder
- American Psychiatric Association — Prolonged Grief Disorder
- AHRQ — Tool: Teach-Back
- American Psychiatric Association — Integrated Behavioral Healthcare
- MedlinePlus — Parkinson's Disease
- AMA Code of Medical Ethics — Informed Consent
- American Psychiatric Association — Depression
- American Psychiatric Association — Somatic Symptom Disorder
- Cochrane Handbook — Chapter 15: Interpreting Results and Drawing Conclusions
- American Psychiatric Association — DSM-5-TR Update, September 2024, with Previous Updates
- Multimodal MRI markers of nigrostriatal pathology in Parkinson's disease (U01) | PDBP
- Psychiatry.org - What is Hoarding Disorder?
- Psychiatry.org - What Is Depression?
- mdd.pdf
- APA_DSM-5-Somatic-Symptom-Disorder.pdf
- Psychiatry.org - APA Offers Tips for Understanding Prolonged Grief Disorder
- Resource-Document-2019-Decisional-Capacity-Determinations-in-Consultation-Liaison-Psychiatry.pdf
- Psychiatry.org - What Are Bipolar Disorders?
- Psychiatry.org - What is Schizophrenia?
- sensitivity-of-revised-diagnostic-criteria-for-the.pdf
- Advance Directives | AMA Code of Medical Ethics
- These highlights do not include all the information needed to use CLOZAPINE TABLETS safely and effectively. See full prescribing information for CLOZAPINE TABLETS. CLOZAPINE tablets, for oral use Initial U.S. Approval: 1989
- Naltrexone Hydrochloride Tablets, USP Opioid Antagonist
- DailyMed - ACAMPROSATE CALCIUM tablet, delayed release
- Disulfiram Tablets, USP
- DailyMed - QUETIAPINE tablet, film coated
- DailyMed - LAMICTAL- lamotrigine tablet LAMICTAL- lamotrigine tablet, for suspension LAMICTAL ODT- lamotrigine tablet, orally disintegrating LAMICTAL- lamotrigine kit
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.